These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26645912)

  • 1. The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis.
    Liu L; Yin W; Wang R; Sun D; He X; Ding Y
    Inflamm Res; 2016 Feb; 65(2):161-8. PubMed ID: 26645912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
    Li X; Chen Y; Tang Y; Ding Y; Xu Q; Sun L; Qian W; Qian G; Qin L; Lv H
    Eur J Pediatr; 2018 Aug; 177(8):1279-1292. PubMed ID: 29948255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
    Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
    PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal liver panel in acute kawasaki disease.
    Eladawy M; Dominguez SR; Anderson MS; Glodé MP
    Pediatr Infect Dis J; 2011 Feb; 30(2):141-4. PubMed ID: 20861758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
    Hashimoto I
    Pediatr Int; 2019 Jul; 61(7):641-646. PubMed ID: 31132210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study.
    Yan Y; Qiao L; Hua Y; Shao S; Zhang N; Wu M; Liu L; Zhou K; Liu X; Wang C
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):147. PubMed ID: 34563210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.
    Sano T; Kurotobi S; Matsuzaki K; Yamamoto T; Maki I; Miki K; Kogaki S; Hara J
    Eur J Pediatr; 2007 Feb; 166(2):131-7. PubMed ID: 16896641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F; Ding Y; Yin W
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.
    Pagnini I; Marino A; Simonini G; Cimaz R
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S170. PubMed ID: 22410254
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.
    Chen S; Dong Y; Yin Y; Krucoff MW
    Heart; 2013 Jan; 99(2):76-82. PubMed ID: 22869678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
    Kobayashi T; Inoue Y; Takeuchi K; Okada Y; Tamura K; Tomomasa T; Kobayashi T; Morikawa A
    Circulation; 2006 Jun; 113(22):2606-12. PubMed ID: 16735679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
    Ha KS; Lee J; Jang GY; Lee J; Lee KC; Son CS; Lee JW
    Am J Cardiol; 2015 Jul; 116(2):301-6. PubMed ID: 25975725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.
    Fukunishi M; Kikkawa M; Hamana K; Onodera T; Matsuzaki K; Matsumoto Y; Hara J
    J Pediatr; 2000 Aug; 137(2):172-6. PubMed ID: 10931407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
    Chan H; Chi H; You H; Wang M; Zhang G; Yang H; Li Q
    BMC Pediatr; 2019 May; 19(1):158. PubMed ID: 31101091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.
    Masuda H; Ae R; Koshimizu TA; Kosami K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Clin Rheumatol; 2022 Oct; 41(10):3125-3133. PubMed ID: 35798922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
    Kanamitsu K; Kakimoto H; Shimada A; Nakata Y; Ochi H; Watanabe H; Iwasaki Y; Tokorodani C; Kanazawa A; Maruyama H; Miyazawa M; Nishiuchi R; Kikkawa K
    Pediatr Int; 2016 Feb; 58(2):146-51. PubMed ID: 26190225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.